Researchers test skin cancer drug for Alzheimer's treatment

09/12/2013 | KSNV-TV (Las Vegas)

A landmark study is being conducted in Las Vegas to determine the effect of bexarotene, an established skin cancer drug, on patients with Alzheimer's disease. The trial was initiated after the drug was linked to cognitive improvements in mice. Patients will undergo brain imaging to assess changes in their neurological condition.

View Full Article in:

KSNV-TV (Las Vegas)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA